TAF II p68, also known as TAF4B, is a transcription factor that plays a critical role in the initiation of transcription by RNA polymerase II. It is a part of the TFIID complex, an assemblage of TATA-binding proteins and associated factors, which are essential for the activation of eukaryotic genes. TAF II p68 Activators are a diverse set of compounds that enhance the functional activity of TAF II p68 through various mechanisms, thereby influencing the transcriptional machinery. These activators function by stabilizing the protein or facilitating its incorporation into the TFIID complex. For example, certain small molecule stabilizers can bind to TAF II p68 directly, enhancing its structural integrity and promoting its interaction with other transcription factors. This increased stability and enhanced interaction drive the formation of a more robust transcription complex, thereby amplifying the transcription of genes controlled by TAF II p68. Furthermore, some activators might affect the post-translational modifications of TAF II p68, such as phosphorylation, which can modulate its activity and its ability to recruit RNA polymerase II to promoters.
The efficacy of TAF II p68 Activators lies in their ability to indirectly promote gene expression by targeting the dynamics of the transcription pre-initiation complex. These compounds may also work by altering the cellular concentration of cofactors required for optimal TAF II p68 function or by facilitating the assembly of TFIID complex components. For instance, certain ligands may enhance the binding affinity of TAF II p68 for TBP-associated factors, leading to a more stable and efficient transcription initiation complex. Additionally, some activators might interact with the DNA binding domain of TAF II p68, thereby facilitating its binding to specific promoter regions and enhancing the recruitment of the TFIID complex. These mechanisms ensure that genes under the regulatory purview of TAF II p68 are transcribed effectively, maintaining cellular functions that depend on these specific genetic programs. The precise activity of these activators is crucial for maintaining the delicate balance of gene expression that is critical for normal cell function and response to environmental signals.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels which can enhance the function of TAF II p68 by cAMP-dependent protein kinase (PKA) phosphorylation, a modification that may influence its role in transcription initiation. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a phosphodiesterase inhibitor, prevents the breakdown of cAMP, potentially enhancing TAF II p68 activity through similar cAMP-dependent pathways as Forskolin. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, another phosphodiesterase inhibitor, increases cAMP levels, potentially enhancing TAF II p68 activity by promoting PKA-mediated phosphorylation processes. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast, like Rolipram and IBMX, increases cAMP by inhibiting phosphodiesterases, potentially enhancing the phosphorylation and activity of TAF II p68. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that could enhance TAF II p68 activity by inhibiting kinases that may negatively regulate its function within transcription complexes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, another histone deacetylase inhibitor, can enhance the chromatin structure for TAF II p68 binding and function in the transcription initiation complex. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can inhibit NF-κB signaling, potentially enhancing TAF II p68 activity by mitigating inhibitory effects that NF-κB may exert on transcription initiation where TAF II p68 is involved. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has been shown to modulate sirtuin activity, which may enhance TAF II p68 function by altering the chromatin structure favorably for transcription initiation. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is a phosphodiesterase inhibitor that can increase cAMP levels, potentially enhancing TAF II p68 activity through cAMP-dependent protein kinase pathways. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX-01294, a histone methyltransferase inhibitor, may enhance TAF II p68 activity by reducing histone H3K9 methylation, thus promoting a chromatin state conducive to transcription initiation. | ||||||